Hereditary Necrotizing Myelopathy (ENM) in Kooikerhondje Dogs

Hereditary necrotizing myelopathy (ENM), sometimes called leukodystrophy or Kooiker paralysis, is a serious genetic condition in Kooikerhondje dogs that affects the spinal cord. This progressive neurological disorder usually develops between 3 and 15 months of age, leading to worsening mobility problems that eventually result in paralysis and death.

The condition causes gradual deterioration of the spinal cord's white matter, driven by a genetic mutation in the IBA57 gene. Although spinal cord damage from ENM isn’t painful, paralysis severely impacts the dog’s quality of life.

How ENM Impacts Kooikerhondje Dogs

Early symptoms often include weakness in the hind legs, unusual gait patterns, and worn toenails from dragging or scuffing. These signs commonly appear between 3 and 12 months, occasionally as late as 15 months. As the disease advances, paralysis spreads from the back legs to the front legs, eventually causing total paralysis and difficulty breathing.

Sadly, most affected Kooikerhondjes do not survive beyond two years of age, with euthanasia considered to relieve suffering. While there is no cure or effective treatment in the U.S., recognizing symptoms early is key for management and breeding decisions.

Genetics and Inheritance

ENM is inherited as an autosomal recessive disorder, meaning a dog must inherit two copies of the mutated gene—one from each parent—to develop the disease. There are three possible genetic statuses for dogs:

• Clear: Dogs with no copies of the mutation; they neither develop nor pass on ENM.
• Carrier: Dogs with one copy of the mutation; they typically show no symptoms but can transmit the mutation to offspring.
• Affected: Dogs with two copies of the mutated gene, resulting in disease manifestation.

The combination of parents’ genetic statuses affects the chances of affected puppies:

• Two clear dogs produce only clear puppies.
• Two carriers have a 25% chance of affected puppies, 50% carriers, and 25% clear puppies.
• A carrier bred with a clear dog results in 50% carriers and 50% clear puppies.
• An affected dog bred with a clear dog produces all carriers.
• An affected dog bred with a carrier results in 50% affected and 50% carrier puppies.
• Two affected dogs produce 100% affected puppies.

Testing and Diagnosis

Diagnosis involves observing clinical signs such as an abnormal gait and diminished reflexes in the hind limbs. Advanced imaging techniques like MRI can show lesions in the spinal cord. Nonetheless, the cornerstone of ENM prevention is genetic testing of potential breeding dogs.

In the United States, reputable Kooikerhondje breeders are encouraged to have their dogs DNA tested through accredited veterinary genetic labs. Testing typically requires a blood or cheek swab sample collected by a certified veterinarian.

These genetic screenings allow breeders to avoid mating two carriers or two affected dogs, which helps lower ENM’s occurrence in the US Kooikerhondje population over time.

Responsible Breeding and Prevention

Because ENM is severe and irreversible, responsible breeding is crucial to prevent the disease’s spread. Avoiding mating two carriers or an affected dog with carriers reduces the risk of affected litters.

With consistent genetic testing and thoughtful mate selection, American breeders can significantly limit ENM cases, mirroring successes seen in European Kooikerhondje communities.

Conclusion

Hereditary necrotizing myelopathy is a devastating genetic disorder mainly affecting Kooikerhondje dogs. Although it is progressive and fatal, awareness, early detection, and genetic testing can reduce its impact.

For those who breed or are interested in owning a Kooikerhondje in the U.S., consult your veterinarian about genetic testing. Responsible screening helps maintain breed health and protects these charming dogs from unnecessary suffering.